Controversies in Stroke Care
Original Event: Feb. 28, 2013
Note: Accreditation for this program has expired. This program is for informational purposes only.
Other On-demand Accredited Webinars in This Series
Redefining Exclusion/Inclusion Criteria for IV tPA Use, Original program: Jun. 20, 2012
Rehabilitation for Stroke Patients, Original program: Jan. 23, 2013This activity is jointly sponsored by Medical Education Resources and National Stroke Association.
Significant knowledge and practice gaps exist across the continuum of stroke care. Stroke is highly preventable, yet nearly 800,000 strokes occur each year. Although effective treatments exist that could benefit up to 40 percent of stroke patients, fewer than 10 percent of stroke patients actually receive these treatments.
Controversy is a hallmark of new ideas in medicine. As an education strategy, the identification and exploration of controversial topics enables an effective debate about unresolved issues, resulting in greater consensus supported by evidence-based medicine and expert opinion.
This webinar will include discussions of criteria used to assess intervention decisions and the reaction to three reviews of acute intervention studies and trials presented at the 2013 International Stroke Conference.
The target audience for this activity includes neurologists, neuroscience nurses, emergency department physicians and nurses, hospitalists and others involved in the acute treatment of stroke patients.
To increase healthcare professionals’ knowledge of the controversies surrounding interventional treatments in acute stroke patients. This webinar will include the following intervention topics:
- Utilize evidence based and professional practice based knowledge to make decisions about acute stroke interventions
- Apply evidence-based knowledge of neurothrombectomy devices when making treatment decisions for acute stroke patients
- Interpret controversies between evidence-based practice and clinical utility for acute stroke treatment
Mark J. Alberts, MD
Professor of Neurology
University of Texas Southwestern Medical Center at Dallas
Robert Ferguson, MD
Chair of Radiology
Richard Latchaw, MD
Professor of Radiology
UC Davis Medical Center
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Medical Education Resources to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
reported the following financial relationships with commercial interests whose
services may be mentioned in this CME activity:
Dr. Mark Alberts is a speaker/consultant for Genentech, Inc.
Dr. Robert Ferguson has no financial relationships to disclose.
Dr. Richard Latchaw has 5 percent ownership of NexGen Medical Systems, Inc. and three patents for endovascular devices.
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
Denise Henasey, National
Stroke Association, has no financial relationships to disclose.
Julie Johnson, PharmD, MER, has no financial relationships to disclose.
Veronda Smith, FNP-BC, MER, has no financial relationships to disclose.
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, National Stroke Association, Genentech and/or Penumbra Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, National Stroke Association, Genentech and/or Penumbra Inc. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.
If you have any questions about this program, contact firstname.lastname@example.org.
Controversies in Stroke Care Webinar Series
|Redefining Inclusion/Exclusion Criteria for IV tPA Use|
|Rehabilitation for Stroke Patients|